Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD (PINNACLE 2)

ClinicalTrials.gov ID: NCT01854658

Public ClinicalTrials.gov record NCT01854658. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 1:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind (Test Products and Placebo), Chronic Dosing (24 Weeks), Placebo-Controlled, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD, Compared With Placebo

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multicenter, randomized, double-blind, parallel group, chronic-dosing (24 weeks), placebo-controlled study to assess the efficacy and safety of Glycopyrrolate (GP and Formoterol Fumarate (FF) combination metered-dose inhaler (MDI) (GFF; PT003), GP MDI (PT001), and FF MDI (PT005) compared with Placebo MDI in subjects with moderate to very severe COPD.

Study identification

NCT ID
NCT01854658
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pearl Therapeutics, Inc.
Industry
Enrollment
1,615 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2013 (Type not available)
Primary completion
Mar 2015 (Actual)
Completion
Mar 2015 (Actual)
Last update posted
Mar 28, 2017

2013 – 2015

United States locations

U.S. sites
113
U.S. states
31
U.S. cities
113
Facility City State ZIP Site status
Pearl Investigative Site Birmingham Alabama — —
Pearl Investigative Site Florence Alabama — —
Pearl Investigative Site Jasper Alabama — —
Pearl Investigative Site Mobile Alabama — —
Pearl Investigative Site Fullerton California — —
Pearl Investigative Site Gold River California — —
Pearl Investigative Site Long Beach California — —
Pearl Investigative Site Los Angeles California — —
Pearl Investigative Site Mission Hills California — —
Pearl Investigative Site Newport Beach California — —
Pearl Investigative Site North Hollywood California — —
Pearl Investigative Site Northridge California — —
Pearl Investigative Site Rancho Mirage California — —
Pearl Investigative Site Rialto California — —
Pearl Investigative Site Rolling Hills Estates California — —
Pearl Investigative Site San Diego California — —
Pearl Investigative Site Santa Monica California — —
Pearl Investigative Site Stockton California — —
Pearl Investigative Site Torrance California — —
Pearl Investigative Site Wildomar California — —
Pearl Investigative Site Centennial Colorado — —
Pearl Investigative Site Boynton Beach Florida — —
Pearl Investigative Site Clearwater Florida — —
Pearl Investigative Site Hialeah Florida — —
Pearl Investigative Site Jacksonville Florida — —
Pearl Investigative Site Kissimmee Florida — —
Pearl Investigative Site Melbourne Florida u —
Pearl Investigative Site Miami Florida — —
Pearl Investigative Site New Port Richey Florida — —
Pearl Investigative Site Orlando Florida — —
Pearl Investigative Site Ormond Beach Florida — —
Pearl Investigative Site Port Orange Florida — —
Pearl Investigative Site Sanford Florida — —
Pearl Investigative Site Sebring Florida — —
Pearl Investigative Site Tamarac Florida — —
Pearl Investigative Site Winter Park Florida — —
Pearl Investigative Site Lawrenceville Georgia — —
Pearl Investigative Site Norcross Georgia — —
Pearl Investigative Site Smyrna Georgia — —
Pearl Investigative Site Elk Grove Illinois — —
Pearl Investigative Site Normal Illinois — —
Pearl Investigative Site Peoria Illinois — —
Pearl Investigative Site Evansville Indiana — —
Pearl Investigative Site Franklin Indiana — —
Pearl Investigative Site Lafayette Indiana — —
Pearl Investigative Site South Bend Indiana — —
Pearl Investigative Site Council Bluffs Iowa — —
Pearl Investigative Site Hazard Kentucky — —
Pearl Investigative Site Louisville Kentucky — —
Pearl Investigative Site Paducah Kentucky — —
Pearl Investigative Site Lake Charles Louisiana — —
Pearl Investigative Siteq Baltimore Maryland — —
Pearl Investigative Site Columbia Maryland — —
Pearl Investigative Site Haverhill Massachusetts — —
Pearl Investigative Site North Dartmouth Massachusetts — —
Pearl Investigative Site Ann Arbor Michigan — —
Pearl Investigative Site Fridley Minnesota — —
Pearl Investigative Site Minneapolis Minnesota — —
Pearl Investigative Site Rochester Minnesota — —
Pearl Investigative Site Saint Charles Missouri — —
Pearl Investigative Site St Louis Missouri — —
Pearl Investigative Site Fremont Nebraska — —
Pearl Investigative Site Omaha Nebraska — —
Pearl Investigative Site Henderson Nevada — —
Pearl Investigative Site Newington New Hampshire — —
Pearl Investigative Site Cedar Knolls New Jersey — —
Pearl Investigative Site Marlton New Jersey — —
Pearl Investigative Site Buffalo New York — —
Pearl Investigative Site New York New York — —
Pearl Investigative Site Rochester New York — —
Pearl Investigative Site Boone North Carolina — —
Pearl Investigative Site Charlotte North Carolina — —
Pearl Investigative Site Hendersonville North Carolina — —
Pearl Investigative Site Raleigh North Carolina — —
Pearl Investigative Site Winston-Salem North Carolina — —
Pearl Investigative Site Akron Ohio — —
Pearl Investigative Site Canton Ohio — —
Pearl Investigative Site Cincinnati Ohio — —
Pearl Investigative Site Columbus Ohio — —
Pearl Investigative Site Willoughby Ohio — —
Pearl Investigative Site Oklahoma City Oklahoma — —
Pearl Investigative Site Tulsa Oklahoma — —
Pearl Investigative Site Portland Oregon — —
Pearl Investigative Site Hershey Pennsylvania — —
Pearl Investigative Site Phoenixville Pennsylvania — —
Pearl Investigative Site Pittsburgh Pennsylvania — —
Pearl Investigative Site Anderson South Carolina — —
Pearl Investigative Site Charleston South Carolina — —
Pearl Investigative Site Easley South Carolina — —
Pearl Investigative Site Fort Mill South Carolina — —
Pearl Investigative Site Gaffney South Carolina — —
Pearl Investigative Site Greenville South Carolina — —
Pearl Investigative Site Rock Hill South Carolina — —
Pearl Investigative Site Seneca South Carolina — —
Pearl Investigative Site Spartanburg South Carolina — —
Pearl Investigative Site Nashville Tennessee — —
Pearl Investigative Site Arlington Texas — —
Pearl Investigative Site Beaumont Texas — —
Pearl Investigative Site Boerne Texas — —
Pearl Investigative Site Corsicana Texas — —
Pearl Investigative Site Dallas Texas — —
Pearl Investigative Site Fort Worth Texas — —
Pearl Investigative Site Houston Texas — —
Pearl Investigative Site San Antonio Texas — —
Pearl Investigative Site Tomball Texas — —
Pearl Investigative Site Waco Texas — —
Pearl Investigative Site Midlothian Virginia — —
Pearl Investigative Site Newport News Virginia — —
Pearl Investigative Site Richmond Virginia — —
Pearl Investigative Site Ricmond Virginia — —
Pearl Investigative Site Spokane Washington — —
Pearl Investigative Site Tacoma Washington — —
Pearl Investigative Site Bridgeport West Virginia — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01854658, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 28, 2017 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01854658 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →